Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography

To correlate fractal dimension (FD) of the retinal vasculature with the extent of retinal nonperfusion area in diabetic retinopathy (DR) on ultrawide-field fluorescein angiography (FA). Cross-sectional study. Baseline Optos 200Tx ultrawide-field FA images of 80 eyes with DR from the DAVE (NCT0155240...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of ophthalmology 2020-01, Vol.209, p.99-106
Hauptverfasser: Fan, Wenying, Nittala, Muneeswar Gupta, Fleming, Alan, Robertson, Gavin, Uji, Akihito, Wykoff, Charles C., Brown, David M., van Hemert, Jano, Ip, Michael, Wang, Kang, Falavarjani, Khalil Ghasemi, Singer, Michael, Sagong, Min, Sadda, SriniVas R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 106
container_issue
container_start_page 99
container_title American journal of ophthalmology
container_volume 209
creator Fan, Wenying
Nittala, Muneeswar Gupta
Fleming, Alan
Robertson, Gavin
Uji, Akihito
Wykoff, Charles C.
Brown, David M.
van Hemert, Jano
Ip, Michael
Wang, Kang
Falavarjani, Khalil Ghasemi
Singer, Michael
Sagong, Min
Sadda, SriniVas R.
description To correlate fractal dimension (FD) of the retinal vasculature with the extent of retinal nonperfusion area in diabetic retinopathy (DR) on ultrawide-field fluorescein angiography (FA). Cross-sectional study. Baseline Optos 200Tx ultrawide-field FA images of 80 eyes with DR from the DAVE (NCT01552408) and RECOVERY (NCT02863354) studies were stereographically projected at the Doheny Image Reading Center. The retinal vasculature was extracted from an early-phase FA frame by exploiting the elongated nature of the vessels and then skeletonized for calculation of FD using a box-counting method. The nonperfusion area was delineated by 2 independent, reading center–certified graders who were masked to the study groups and who were using a standardized protocol and then computed in millimeters squared. While no difference in FD was observed for the entire retina in DR compared with normal control subjects, a significantly smaller FD was found in the far-periphery of the DR eyes (P < .001). FD for the entire retina was negatively associated with global nonperfusion area (R = −0.44; P < .001), and this relationship was also present within the 3 concentric retinal zones (posterior: R = −0.31, P = .016; midperiphery: R = −0.35, P = .007; and far periphery: R = −0.31, P = .015). Peripheral FD on ultrawide-field FA is reduced in DR eyes compared with normal eyes and is correlated with severity of retinal nonperfusion. FD can be calculated automatically without the need for correction of peripheral distortion, and therefore it may prove to be a useful surrogate biomarker when precise quantification of nonperfusion is not feasible.
doi_str_mv 10.1016/j.ajo.2019.08.015
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2283105472</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002939419304167</els_id><sourcerecordid>2323396901</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-13f361db17180845b854b2e46f7e375ca6b3541309ab39afb76f57cc50a228e43</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS0EotvCD-CCInHhkuCJnTgRp7Z0AakCqaJny3EmXUdZO9gJ1V755UzZwoEDp5E933savcfYK-AFcKjfjYUZQ1FyaAveFByqJ2wDjWpzaFp4yjac8zJvRStP2GlKIz1rJdVzdiJAqhJqvmE_b3Ayiws-7dycXeByj-izG1ycN1O2jcYuND-4PfpEVGZ8n30JfsY4rL8_nKet6Uhgj7Iwm2V3yGh1Oy3R3Lse863Dqc-20xoiJoukOfd3LtxFM-8OL9izwUwJXz7OM3a7vfp2-Sm__vrx8-X5dW6lVEsOYhA19B0oaHgjq66pZFeirAeFQlXW1J2oJAjemk60ZuhUPVTK2oqbsmxQijP29ug7x_B9xbTovaNjpsl4DGvSRAngFSVD6Jt_0DGskRIhSpRCtHXLgSg4UjaGlCIOeo5ub-JBA9cPBelRU0H6oSDNG00Fkeb1o_Pa7bH_q_jTCAHvjwBSFD8cRp2sQ2-xdxHtovvg_mP_C8dfoZM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2323396901</pqid></control><display><type>article</type><title>Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Fan, Wenying ; Nittala, Muneeswar Gupta ; Fleming, Alan ; Robertson, Gavin ; Uji, Akihito ; Wykoff, Charles C. ; Brown, David M. ; van Hemert, Jano ; Ip, Michael ; Wang, Kang ; Falavarjani, Khalil Ghasemi ; Singer, Michael ; Sagong, Min ; Sadda, SriniVas R.</creator><creatorcontrib>Fan, Wenying ; Nittala, Muneeswar Gupta ; Fleming, Alan ; Robertson, Gavin ; Uji, Akihito ; Wykoff, Charles C. ; Brown, David M. ; van Hemert, Jano ; Ip, Michael ; Wang, Kang ; Falavarjani, Khalil Ghasemi ; Singer, Michael ; Sagong, Min ; Sadda, SriniVas R.</creatorcontrib><description>To correlate fractal dimension (FD) of the retinal vasculature with the extent of retinal nonperfusion area in diabetic retinopathy (DR) on ultrawide-field fluorescein angiography (FA). Cross-sectional study. Baseline Optos 200Tx ultrawide-field FA images of 80 eyes with DR from the DAVE (NCT01552408) and RECOVERY (NCT02863354) studies were stereographically projected at the Doheny Image Reading Center. The retinal vasculature was extracted from an early-phase FA frame by exploiting the elongated nature of the vessels and then skeletonized for calculation of FD using a box-counting method. The nonperfusion area was delineated by 2 independent, reading center–certified graders who were masked to the study groups and who were using a standardized protocol and then computed in millimeters squared. While no difference in FD was observed for the entire retina in DR compared with normal control subjects, a significantly smaller FD was found in the far-periphery of the DR eyes (P &lt; .001). FD for the entire retina was negatively associated with global nonperfusion area (R = −0.44; P &lt; .001), and this relationship was also present within the 3 concentric retinal zones (posterior: R = −0.31, P = .016; midperiphery: R = −0.35, P = .007; and far periphery: R = −0.31, P = .015). Peripheral FD on ultrawide-field FA is reduced in DR eyes compared with normal eyes and is correlated with severity of retinal nonperfusion. FD can be calculated automatically without the need for correction of peripheral distortion, and therefore it may prove to be a useful surrogate biomarker when precise quantification of nonperfusion is not feasible.</description><identifier>ISSN: 0002-9394</identifier><identifier>EISSN: 1879-1891</identifier><identifier>DOI: 10.1016/j.ajo.2019.08.015</identifier><identifier>PMID: 31472160</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Angiogenesis Inhibitors - therapeutic use ; Combined Modality Therapy ; Cross-Sectional Studies ; Diabetic retinopathy ; Diabetic Retinopathy - diagnosis ; Diabetic Retinopathy - physiopathology ; Diabetic Retinopathy - therapy ; Female ; Fluorescein Angiography - methods ; Fractals ; Humans ; Intravitreal Injections ; Ischemia - diagnosis ; Ischemia - physiopathology ; Laser Coagulation ; Macular Edema - diagnosis ; Macular Edema - physiopathology ; Macular Edema - therapy ; Male ; Medical imaging ; Middle Aged ; Ophthalmology ; Prospective Studies ; Ranibizumab - therapeutic use ; Receptors, Vascular Endothelial Growth Factor - therapeutic use ; Recombinant Fusion Proteins - therapeutic use ; Retina ; Retinal Vessels - pathology ; Vascular Endothelial Growth Factor A - antagonists &amp; inhibitors</subject><ispartof>American journal of ophthalmology, 2020-01, Vol.209, p.99-106</ispartof><rights>2019</rights><rights>Copyright © 2019. Published by Elsevier Inc.</rights><rights>Copyright Elsevier Limited Jan 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-13f361db17180845b854b2e46f7e375ca6b3541309ab39afb76f57cc50a228e43</citedby><cites>FETCH-LOGICAL-c447t-13f361db17180845b854b2e46f7e375ca6b3541309ab39afb76f57cc50a228e43</cites><orcidid>0000-0003-1304-4101 ; 0000-0003-4140-5015</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ajo.2019.08.015$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31472160$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fan, Wenying</creatorcontrib><creatorcontrib>Nittala, Muneeswar Gupta</creatorcontrib><creatorcontrib>Fleming, Alan</creatorcontrib><creatorcontrib>Robertson, Gavin</creatorcontrib><creatorcontrib>Uji, Akihito</creatorcontrib><creatorcontrib>Wykoff, Charles C.</creatorcontrib><creatorcontrib>Brown, David M.</creatorcontrib><creatorcontrib>van Hemert, Jano</creatorcontrib><creatorcontrib>Ip, Michael</creatorcontrib><creatorcontrib>Wang, Kang</creatorcontrib><creatorcontrib>Falavarjani, Khalil Ghasemi</creatorcontrib><creatorcontrib>Singer, Michael</creatorcontrib><creatorcontrib>Sagong, Min</creatorcontrib><creatorcontrib>Sadda, SriniVas R.</creatorcontrib><title>Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography</title><title>American journal of ophthalmology</title><addtitle>Am J Ophthalmol</addtitle><description>To correlate fractal dimension (FD) of the retinal vasculature with the extent of retinal nonperfusion area in diabetic retinopathy (DR) on ultrawide-field fluorescein angiography (FA). Cross-sectional study. Baseline Optos 200Tx ultrawide-field FA images of 80 eyes with DR from the DAVE (NCT01552408) and RECOVERY (NCT02863354) studies were stereographically projected at the Doheny Image Reading Center. The retinal vasculature was extracted from an early-phase FA frame by exploiting the elongated nature of the vessels and then skeletonized for calculation of FD using a box-counting method. The nonperfusion area was delineated by 2 independent, reading center–certified graders who were masked to the study groups and who were using a standardized protocol and then computed in millimeters squared. While no difference in FD was observed for the entire retina in DR compared with normal control subjects, a significantly smaller FD was found in the far-periphery of the DR eyes (P &lt; .001). FD for the entire retina was negatively associated with global nonperfusion area (R = −0.44; P &lt; .001), and this relationship was also present within the 3 concentric retinal zones (posterior: R = −0.31, P = .016; midperiphery: R = −0.35, P = .007; and far periphery: R = −0.31, P = .015). Peripheral FD on ultrawide-field FA is reduced in DR eyes compared with normal eyes and is correlated with severity of retinal nonperfusion. FD can be calculated automatically without the need for correction of peripheral distortion, and therefore it may prove to be a useful surrogate biomarker when precise quantification of nonperfusion is not feasible.</description><subject>Adult</subject><subject>Angiogenesis Inhibitors - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Cross-Sectional Studies</subject><subject>Diabetic retinopathy</subject><subject>Diabetic Retinopathy - diagnosis</subject><subject>Diabetic Retinopathy - physiopathology</subject><subject>Diabetic Retinopathy - therapy</subject><subject>Female</subject><subject>Fluorescein Angiography - methods</subject><subject>Fractals</subject><subject>Humans</subject><subject>Intravitreal Injections</subject><subject>Ischemia - diagnosis</subject><subject>Ischemia - physiopathology</subject><subject>Laser Coagulation</subject><subject>Macular Edema - diagnosis</subject><subject>Macular Edema - physiopathology</subject><subject>Macular Edema - therapy</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Middle Aged</subject><subject>Ophthalmology</subject><subject>Prospective Studies</subject><subject>Ranibizumab - therapeutic use</subject><subject>Receptors, Vascular Endothelial Growth Factor - therapeutic use</subject><subject>Recombinant Fusion Proteins - therapeutic use</subject><subject>Retina</subject><subject>Retinal Vessels - pathology</subject><subject>Vascular Endothelial Growth Factor A - antagonists &amp; inhibitors</subject><issn>0002-9394</issn><issn>1879-1891</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFv1DAQhS0EotvCD-CCInHhkuCJnTgRp7Z0AakCqaJny3EmXUdZO9gJ1V755UzZwoEDp5E933savcfYK-AFcKjfjYUZQ1FyaAveFByqJ2wDjWpzaFp4yjac8zJvRStP2GlKIz1rJdVzdiJAqhJqvmE_b3Ayiws-7dycXeByj-izG1ycN1O2jcYuND-4PfpEVGZ8n30JfsY4rL8_nKet6Uhgj7Iwm2V3yGh1Oy3R3Lse863Dqc-20xoiJoukOfd3LtxFM-8OL9izwUwJXz7OM3a7vfp2-Sm__vrx8-X5dW6lVEsOYhA19B0oaHgjq66pZFeirAeFQlXW1J2oJAjemk60ZuhUPVTK2oqbsmxQijP29ug7x_B9xbTovaNjpsl4DGvSRAngFSVD6Jt_0DGskRIhSpRCtHXLgSg4UjaGlCIOeo5ub-JBA9cPBelRU0H6oSDNG00Fkeb1o_Pa7bH_q_jTCAHvjwBSFD8cRp2sQ2-xdxHtovvg_mP_C8dfoZM</recordid><startdate>202001</startdate><enddate>202001</enddate><creator>Fan, Wenying</creator><creator>Nittala, Muneeswar Gupta</creator><creator>Fleming, Alan</creator><creator>Robertson, Gavin</creator><creator>Uji, Akihito</creator><creator>Wykoff, Charles C.</creator><creator>Brown, David M.</creator><creator>van Hemert, Jano</creator><creator>Ip, Michael</creator><creator>Wang, Kang</creator><creator>Falavarjani, Khalil Ghasemi</creator><creator>Singer, Michael</creator><creator>Sagong, Min</creator><creator>Sadda, SriniVas R.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1304-4101</orcidid><orcidid>https://orcid.org/0000-0003-4140-5015</orcidid></search><sort><creationdate>202001</creationdate><title>Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography</title><author>Fan, Wenying ; Nittala, Muneeswar Gupta ; Fleming, Alan ; Robertson, Gavin ; Uji, Akihito ; Wykoff, Charles C. ; Brown, David M. ; van Hemert, Jano ; Ip, Michael ; Wang, Kang ; Falavarjani, Khalil Ghasemi ; Singer, Michael ; Sagong, Min ; Sadda, SriniVas R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-13f361db17180845b854b2e46f7e375ca6b3541309ab39afb76f57cc50a228e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Angiogenesis Inhibitors - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Cross-Sectional Studies</topic><topic>Diabetic retinopathy</topic><topic>Diabetic Retinopathy - diagnosis</topic><topic>Diabetic Retinopathy - physiopathology</topic><topic>Diabetic Retinopathy - therapy</topic><topic>Female</topic><topic>Fluorescein Angiography - methods</topic><topic>Fractals</topic><topic>Humans</topic><topic>Intravitreal Injections</topic><topic>Ischemia - diagnosis</topic><topic>Ischemia - physiopathology</topic><topic>Laser Coagulation</topic><topic>Macular Edema - diagnosis</topic><topic>Macular Edema - physiopathology</topic><topic>Macular Edema - therapy</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Middle Aged</topic><topic>Ophthalmology</topic><topic>Prospective Studies</topic><topic>Ranibizumab - therapeutic use</topic><topic>Receptors, Vascular Endothelial Growth Factor - therapeutic use</topic><topic>Recombinant Fusion Proteins - therapeutic use</topic><topic>Retina</topic><topic>Retinal Vessels - pathology</topic><topic>Vascular Endothelial Growth Factor A - antagonists &amp; inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fan, Wenying</creatorcontrib><creatorcontrib>Nittala, Muneeswar Gupta</creatorcontrib><creatorcontrib>Fleming, Alan</creatorcontrib><creatorcontrib>Robertson, Gavin</creatorcontrib><creatorcontrib>Uji, Akihito</creatorcontrib><creatorcontrib>Wykoff, Charles C.</creatorcontrib><creatorcontrib>Brown, David M.</creatorcontrib><creatorcontrib>van Hemert, Jano</creatorcontrib><creatorcontrib>Ip, Michael</creatorcontrib><creatorcontrib>Wang, Kang</creatorcontrib><creatorcontrib>Falavarjani, Khalil Ghasemi</creatorcontrib><creatorcontrib>Singer, Michael</creatorcontrib><creatorcontrib>Sagong, Min</creatorcontrib><creatorcontrib>Sadda, SriniVas R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fan, Wenying</au><au>Nittala, Muneeswar Gupta</au><au>Fleming, Alan</au><au>Robertson, Gavin</au><au>Uji, Akihito</au><au>Wykoff, Charles C.</au><au>Brown, David M.</au><au>van Hemert, Jano</au><au>Ip, Michael</au><au>Wang, Kang</au><au>Falavarjani, Khalil Ghasemi</au><au>Singer, Michael</au><au>Sagong, Min</au><au>Sadda, SriniVas R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography</atitle><jtitle>American journal of ophthalmology</jtitle><addtitle>Am J Ophthalmol</addtitle><date>2020-01</date><risdate>2020</risdate><volume>209</volume><spage>99</spage><epage>106</epage><pages>99-106</pages><issn>0002-9394</issn><eissn>1879-1891</eissn><abstract>To correlate fractal dimension (FD) of the retinal vasculature with the extent of retinal nonperfusion area in diabetic retinopathy (DR) on ultrawide-field fluorescein angiography (FA). Cross-sectional study. Baseline Optos 200Tx ultrawide-field FA images of 80 eyes with DR from the DAVE (NCT01552408) and RECOVERY (NCT02863354) studies were stereographically projected at the Doheny Image Reading Center. The retinal vasculature was extracted from an early-phase FA frame by exploiting the elongated nature of the vessels and then skeletonized for calculation of FD using a box-counting method. The nonperfusion area was delineated by 2 independent, reading center–certified graders who were masked to the study groups and who were using a standardized protocol and then computed in millimeters squared. While no difference in FD was observed for the entire retina in DR compared with normal control subjects, a significantly smaller FD was found in the far-periphery of the DR eyes (P &lt; .001). FD for the entire retina was negatively associated with global nonperfusion area (R = −0.44; P &lt; .001), and this relationship was also present within the 3 concentric retinal zones (posterior: R = −0.31, P = .016; midperiphery: R = −0.35, P = .007; and far periphery: R = −0.31, P = .015). Peripheral FD on ultrawide-field FA is reduced in DR eyes compared with normal eyes and is correlated with severity of retinal nonperfusion. FD can be calculated automatically without the need for correction of peripheral distortion, and therefore it may prove to be a useful surrogate biomarker when precise quantification of nonperfusion is not feasible.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31472160</pmid><doi>10.1016/j.ajo.2019.08.015</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-1304-4101</orcidid><orcidid>https://orcid.org/0000-0003-4140-5015</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0002-9394
ispartof American journal of ophthalmology, 2020-01, Vol.209, p.99-106
issn 0002-9394
1879-1891
language eng
recordid cdi_proquest_miscellaneous_2283105472
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adult
Angiogenesis Inhibitors - therapeutic use
Combined Modality Therapy
Cross-Sectional Studies
Diabetic retinopathy
Diabetic Retinopathy - diagnosis
Diabetic Retinopathy - physiopathology
Diabetic Retinopathy - therapy
Female
Fluorescein Angiography - methods
Fractals
Humans
Intravitreal Injections
Ischemia - diagnosis
Ischemia - physiopathology
Laser Coagulation
Macular Edema - diagnosis
Macular Edema - physiopathology
Macular Edema - therapy
Male
Medical imaging
Middle Aged
Ophthalmology
Prospective Studies
Ranibizumab - therapeutic use
Receptors, Vascular Endothelial Growth Factor - therapeutic use
Recombinant Fusion Proteins - therapeutic use
Retina
Retinal Vessels - pathology
Vascular Endothelial Growth Factor A - antagonists & inhibitors
title Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T18%3A25%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationship%20Between%20Retinal%20Fractal%20Dimension%20and%20Nonperfusion%20in%20Diabetic%20Retinopathy%20on%20Ultrawide-Field%20Fluorescein%20Angiography&rft.jtitle=American%20journal%20of%20ophthalmology&rft.au=Fan,%20Wenying&rft.date=2020-01&rft.volume=209&rft.spage=99&rft.epage=106&rft.pages=99-106&rft.issn=0002-9394&rft.eissn=1879-1891&rft_id=info:doi/10.1016/j.ajo.2019.08.015&rft_dat=%3Cproquest_cross%3E2323396901%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2323396901&rft_id=info:pmid/31472160&rft_els_id=S0002939419304167&rfr_iscdi=true